|
| Issue Date | Title | Author(s) |
| 2014 | A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H | Bible, K.C.; Suman, V.J.; Molina, J.R.; Smallridge, R.C.; Maples, W.J.; Menefee, M.E.; Rubin, J.; Karlin, N.; Sideras, K.; Morris III, J.C.; McIver, B.; Hay, I.; Fatourechi, V.; Burton, J.K.; Webster, K.P.; Bieber, C.; Traynor, A.M.; Flynn, P.J.; Goh, B.C. ; Isham, C.R.; Harris, P.; Erlichman, C. |
| Sep-2012 | A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer | Bible, K.C.; Suman, V.J.; Menefee, M.E.; Smallridge, R.C.; Molina, J.R.; Maples, W.J.; Karlin, N.J.; Traynor, A.M.; Kumar, P.; Goh, B.C.; Lim, W.-T. ; Bossou, A.R.; Isham, C.R.; Webster, K.P.; Kukla, A.K.; Bieber, C.; Burton, J.K.; Harris, P.; Erlichman, C. |
| Oct-2010 | Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study | Bible, K.C.; Suman, V.J.; Molina, J.R.; Smallridge, R.C.; Maples, W.J.; Menefee, M.E.; Rubin, J.; Sideras, K.; Morris, J.C.; McIver, B.; Burton, J.K.; Webster, K.P.; Bieber, C.; Traynor, A.M.; Flynn, P.J.; Goh, B.C. ; Tang, H.; Ivy, S.P.; Erlichman, C. |
| 20-Sep-2012 | Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: A multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the mayo phase II consortium and the cancer therapeutics research group | Yeo, W.; Chung, H.C.; Chan, S.L.; Wang, L.Z. ; Lim, R.; Picus, J.; Boyer, M.; Mo, F.K.F.; Koh, J.; Rha, S.Y.; Hui, E.P.; Jeung, H.C.; Roh, J.K.; Yu, S.C.H.; To, K.F.; Tao, Q.; Ma, B.B.; Chan, A.W.H.; Tong, J.H.M.; Erlichman, C.; Chan, A.T.C.; Goh, B.C. |
